Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligoprogressive”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Early research (Phase 1)Looking for participantsNCT03546829
What this trial is testing

Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer

Who this might be right for
Early Stage Non-Small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06592612
What this trial is testing

Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment

Who this might be right for
Hepatocellular CarcinomaOligoprogression
Sun Yat-sen University 70
Early research (Phase 1)Not Yet RecruitingNCT07619599
What this trial is testing

A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainOligoprogressive Lung Non-Small Cell Carcinoma+1 more
City of Hope Medical Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT04974671
What this trial is testing

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaMetastatic Renal Cell CarcinomaOligoprogressive+1 more
Yale University 30
Large-scale testing (Phase 3)Looking for participantsNCT06585007
What this trial is testing

Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerOligoprogressive
Universitaire Ziekenhuizen KU Leuven 246
Large-scale testing (Phase 3)Looking for participantsNCT06523673
What this trial is testing

Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Non-Small Cell Lung CancerNSCLC Stage IVOligoProgressive Metastatic Disease
Second Affiliated Hospital, School of Medicine, Zhejiang University 104
Not applicableLooking for participantsNCT06434480
What this trial is testing

SBRT in HCC With Oligoprogression on First-line Immunotherapy

Who this might be right for
HCC
Chinese University of Hong Kong 30
Not applicableNot Yet RecruitingNCT06882499
What this trial is testing

Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II

Who this might be right for
Breast Cancer, MetastaticMetastatic Breast Cancer
Peter MacCallum Cancer Centre, Australia 74
Testing effectiveness (Phase 2)Active Not RecruitingNCT05089916
What this trial is testing

Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study

Who this might be right for
NSCLCEGFR Positive Non-small Cell Lung CancerOligoprogression
AIO-Studien-gGmbH 42
Testing effectiveness (Phase 2)UnknownNCT04970693
What this trial is testing

Furmonertinib Combined With Radiotherapy for Non-small Cell Lung Cancer With Oligoprogression

Who this might be right for
Non-small Cell Lung CancerOligoprogressive
Sun Yat-sen University 64
Testing effectiveness (Phase 2)Looking for participantsNCT04989725
What this trial is testing

Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer

Who this might be right for
Head and Neck CancerMetastatic CancerOligoprogressive
Centre hospitalier de l'Université de Montréal (CHUM) 46
Not applicableLooking for participantsNCT06103682
What this trial is testing

LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)

Who this might be right for
Non-small Cell Lung CancerOligoprogressiveSmall-cell Lung Cancer
University of California, Davis 100
Testing effectiveness (Phase 2)WithdrawnNCT06331585
What this trial is testing

Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy

Who this might be right for
Low-dose RadiotherapyTumor MicroenvironmentNon-Small Cell Lung Cancer
Hetian District People's Hospital
Large-scale testing (Phase 3)Active Not RecruitingNCT07076693
What this trial is testing

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）

Who this might be right for
OligoProgressive Metastatic DiseaseNon-Small Cell Lung Cancer
Shanghai Chest Hospital 97
Large-scale testing (Phase 3)Looking for participantsNCT06367972
What this trial is testing

Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)

Who this might be right for
OligoProgressive Metastatic Disease
M.D. Anderson Cancer Center 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT03808662
What this trial is testing

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Who this might be right for
TNBC - Triple-Negative Breast CancerTriple Negative Breast CancerNSCLC+4 more
Memorial Sloan Kettering Cancer Center 107
Not applicableLooking for participantsNCT06925984
What this trial is testing

Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)

Who this might be right for
OligoProgressive Metastatic Disease
Jules Bordet Institute 48
Testing effectiveness (Phase 2)UnknownNCT05387044
What this trial is testing

SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors

Who this might be right for
NSCLC Stage IV
Zhejiang Cancer Hospital 28
Testing effectiveness (Phase 2)Ended earlyNCT05846659
What this trial is testing

Study of PULSAR-ICI +/- IMSA101 in Patients With Oligoprogressive Solid Tumor Malignancies

Who this might be right for
Oligoprogressive
ImmuneSensor Therapeutics Inc. 16
Large-scale testing (Phase 3)UnknownNCT03256981
What this trial is testing

Stereotactic Body Radiotherapy for the Treatment of OPD

Who this might be right for
NSCLC
Institute of Cancer Research, United Kingdom 113
Load More Results